Alnylam Pharmaceuticals, Inc.
Methods For Inhibition Of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) Gene Expression
Last updated:
Abstract:
The invention relates methods of using RNAi agents to inhibit expression of HAO1 and methods of treating subjects having, e.g., PH1.
Status:
Application
Type:
Utility
Filling date:
12 Jul 2018
Issue date:
28 May 2020